| Methods |
RCT comparing c7E3 Fab bolus and infusion versus placebo in high‐risk patients ongoing coronary angioplasty. |
| Data |
2099 patients were randomised (1403/696, respectively in each treatment group). |
| Comparisons |
Onsite assessment (local investigator blinded) versus assessment by an AC blinded to allocated treatment. |
| Outcomes |
The outcome selected was non fatal myocardial infarction or death from any cause. This was a prespecified composite of any of the following events in the first 30 days after randomisation. |
| Notes |
The study was identified because it was include in a review of six RCTs (Granger 2008). Data related to the number of events in each treatment group resulting from onsite‐assessor and AC assessments were extracted from this review. |
| Risk of bias |
| Item |
Authors' judgement |
Description |
| Method for selecting cases to adjudicate? |
No |
All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment. |
